Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/200265
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLalana Garcés, Marta-
dc.contributor.authorOrtiz Pastor, Oihana-
dc.contributor.authorSolé Enrech, Gemma-
dc.contributor.authorGuerra Ruiz, Armanado R.-
dc.contributor.authorCasals Mercadal, Gregori-
dc.contributor.authorAlmería Lafuente, Alejandro-
dc.contributor.authorBallesteros Vizoso, María Antonieta-
dc.contributor.authorGabriel Medina, Pablo-
dc.contributor.authorSalgüero Fernández, Sergio-
dc.contributor.authorZamora Trillo, Angielys-
dc.contributor.authorAured de la Serna, Isabel-
dc.contributor.authorHurtado, Juan Carlos-
dc.contributor.authorPérez del Pulgar Gallart, Sofía-
dc.contributor.authorForns, Xavier-
dc.contributor.authorMorales Ruiz, Manuel-
dc.date.accessioned2023-07-04T13:51:40Z-
dc.date.available2023-07-04T13:51:40Z-
dc.date.issued2022-08-15-
dc.identifier.issn2628-491X-
dc.identifier.urihttp://hdl.handle.net/2445/200265-
dc.description.abstractBackground: The diagnosis of hepatitis B virus (HBV) infection requires HBV DNA testing and serologic testing for detection of the surface antigen (HBsAg) and the hepatitis B core antibody (anti-HBc). There is a population of patients with occult HBV infection (OBI), which is not detected by HBsAg or HBV DNA quantification in blood, despite the presence of active replication in the liver.Scope: This document provides a definition of OBI and describes the diagnostic techniques currently used. It also addresses the detection of patients with risk factors and the need for screening for OBI in these patients.Summary:Correct diagnosis of OBI prevents HBV reactivation and transmission. Diagnosis of OBI is based on the detection of HBV DNA in patients with undetectable HBsAg in blood.Perspectives: A high number of patients with OBI may remain undiagnosed; therefore, screening for OBI in patients with factor risks is essential. For a correct diagnosis of OBI, it is necessary that new markers such as ultrasensitive HBsAg are incorporated, and a more comprehensive marker study is performed by including markers such as cccDNA.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherDe Gruyter-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1515/almed-2022-0065-
dc.relation.ispartofAdvances In Laboratory Medicine, 2022, vol. 3, num. 4, p. 321-330-
dc.relation.urihttps://doi.org/10.1515/almed-2022-0065-
dc.rightscc by (c) Lalana Garcés, Marta et al, 2022-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)-
dc.subject.classificationHepatitis B-
dc.subject.classificationSerodiagnòstic-
dc.subject.otherHepatitis B-
dc.subject.otherSerodiagnosis-
dc.titleControl of occult hepatitis B virus infection-
dc.typeinfo:eu-repo/semantics/other-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2023-07-03T09:50:34Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina9346686-
dc.identifier.pmid37363431-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
Control of occult hepatitis B virus infection_AdvLabMed.pdf688.49 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons